Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nimble Science has developed and commercialized the SIMBA GI Platform—a first-in-class ingestible capsule that autonomously collects, seals, and preserves multiomic fluid biopsies from the small intestine. This enables at-home collection of high-quality samples to generate actionable insights into gut microbiome composition and function. The technology supports pharmaceutical, diagnostic, food/supplement companies in R&D by providing access to previously inaccessible regions of the GI tract. It has been recognized with industry awards such as NutraIngredients-USA Start-up of the Year in 2024. No direct clinical results are reported since it’s a data/diagnostic platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nimble Science.